Truemors
is reporting from
Member
NP Rank:
NP Rank:
Satyam Buckles Under Investor Pressure : Calls Off Maytas Deal
Satyam Chairman B Ramalinga Raju had to retract his steps after a 55% drop in its ADR in NYSE in US, a loss that was directionally against the rally on US brouses forced Satyam to call off its acquisition of... Eurand added to NASDAQ Biotechnology Index
"Eurand is a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. Eurand has had four products approved by the FDA since 2001 and has a pipeline of product candidates in...
Recent Comments
Top Members Today
Top Rookies
Top Veterans
38
pointsrayrayturner
New York, United States
30
pointsTtim
Dallas, Texas, United States- 4
pointskatterine
Los Angeles, United States
